The Medical Journalists’ Association is delighted to announce that Novartis UK will be the principal sponsor of the 2026 MJA Awards.
A strong, independent health and medical press is critical to a well-functioning healthcare system.
By supporting the Medical Journalists’ Association Awards, we’re recognising the vital role that responsible, high-quality journalism plays in building trust, improving understanding and enabling informed dialogue on health and science. We are incredibly proud to partner with the Medical Journalists’ Association in celebrating the journalists whose work informs, challenges and inspires.
Meghan O’Donnell,
Head of Communications & Patient Advocacy, Novartis UK
About Novartis
Our purpose is to reimagine medicine to improve and extend people’s lives.
We use innovative science and technology to address some of society’s most challenging healthcare issues and we work together with the system to implement solutions that drive access for UK patients.
From research to delivery, we are a valued partner in the healthcare ecosystem, supporting in times of crisis and beyond, to build solutions that provide better care and access opportunities for every patient in the UK.
The Novartis General Media Relations office can be contacted via email at: press.office@novartis.com